# Effect of GLP-1 Receptor Agonists on Trabecular Bone Score

> **NCT04964388** · PHASE2 · TERMINATED · sponsor: **University of Mississippi Medical Center** · enrollment: 5 (actual)

## Conditions studied

- Osteoporosis, Postmenopausal
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** GLP-1 receptor agonist

## Key facts

- **NCT ID:** NCT04964388
- **Lead sponsor:** University of Mississippi Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-11-09
- **Primary completion:** 2023-05-01
- **Final completion:** 2023-07-01
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Not able to recruit participants
- **Last updated:** 2025-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04964388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04964388, "Effect of GLP-1 Receptor Agonists on Trabecular Bone Score". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT04964388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*